Review: Metabolism of immunosuppressant drugs

Current Drug Metabolism

Volumn 3, Issue 3, 2002, Pages 275-287

  Kelly, Patrick ^a   Kahan, Barry D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; 7 ETHOXYCOUMARIN; AZATHIOPRINE; CHLORZOXAZONE; CYCLOSPORIN A; CYCLOSPORIN G; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; DEXAMETHASONE; EVEROLIMUS; FINGOLIMOD; GESTODENE; GLUCOCORTICOID; HYPERICUM PERFORATUM EXTRACT; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NIFEDIPINE; NITRIC OXIDE SYNTHASE; PHENOBARBITAL; RAPAMYCIN; TACROLIMUS; TROLEANDOMYCIN; UNINDEXED DRUG; XANTHINE OXIDASE; CYTOCHROME P450; GLYCOPROTEIN P;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG EFFECT; DRUG METABOLISM; DRUG MONITORING; DRUG POTENCY; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INDIVIDUALIZATION; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; LIVER MICROSOME METABOLISM; NEUROTOXICITY; NONHUMAN; OSTEOPENIA; PLEIOTROPY; RAT; REVIEW; VASCULAR RESISTANCE; CLINICAL TRIAL; DRUG INTERACTION; METABOLISM; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; CLINICAL TRIALS; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; HUMAN; IMMUNOSUPPRESSIVE AGENTS; P-GLYCOPROTEIN; SUPPORT, U.S. GOV'T, P.H.S.; HUMANS;

EID: 0035987193     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389200023337630     Document Type: Review

References (155)